Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel

Summary

Verrica Pharmaceuticals granted Medomie Pharma an exclusive distribution and marketing agreement for YCANTH® in Israel for the treatment of molluscum contagiosum. The deal allows Medomie to seek regulatory approval and distribute the drug in the Israeli market.